CHEK2

This MedLibrary.org supplementary page on CHEK2 is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Related Sponsors

BM Pharmacy Generic pharmaceuticals at unbeatable prices. Insomnia, men's health, hair health, pain control. bmpharmacy.com
Online Pharmacy Carisoprodol, tadalafil, sildenafil, vardenafil and more... xlpharmacy.com
MedBasket.com Discreet. Inexpensive. Fast shipping. Great selection. What more can we say? medbasket.com
Frugalmed 2000 reasons to shop with us first. frugalmed.com
Ads by Tiva

CHK2 checkpoint homolog (S. pombe)
PDB rendering based on 1gxc.
Available structures: 1gxc, 2cn5, 2cn8
Identifiers
Symbols CHEK2; CDS1; CHK2; HuCds1; LFS2; PP1425; RAD53
External IDs OMIM: 604373 MGI: 1355321 HomoloGene: 38289
EC number 2.7.1.37
RNA expression pattern

More reference expression data
Orthologs
Human Mouse
Entrez 11200 50883
Ensembl ENSG00000183765 ENSMUSG00000029521
Uniprot O96017 Q543W6
Refseq NM_001005735 (mRNA)
NP_001005735 (protein)		 NM_016681 (mRNA)
NP_057890 (protein)
Location Chr 22: 27.41 - 27.47 Mb Chr 5: 111.08 - 111.11 Mb
Pubmed search [1] [2]

CHEK2 is the official symbol for the human gene CHK2 checkpoint homolog. It is located on the long (q) arm of chromosome 22.123

Contents

Function

The protein encoded by this gene, CHK2 a protein kinase that is activated in response to DNA damage and is involved in cell cycle arrest.1

In response to DNA damage and replication blocks, cell cycle progression is halted through the control of cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1.4 In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage.56

Related conditions

A mutation in CHEK2 gene results in decreased DNA-repair, or inability of the cell to undergo apoptosis when it ought to have done so. Thus, a mutation leads to an increased susceptibility to cancer. The following conditions are examples of such cancers.

Breast cancer

A deletion-mutation at position 1100 of the CHEK2 gene is associated with an increased risk of breast cancer, particularly in the European population. In women of Northern an Eastern European descent CHEK2*1100delC carrier status confers a 2-3 fold risk of breast cancer. In this ethnic group, women with a familial history of breast cancer have a 4.8 fold risk of breast cancer equal to a life time risk of breast cancer of 37%.7

Li-Fraumeni syndrome

The CHEK2*1100delC mutation was originally associated with the Li-Fraumeni syndrome,8 however the relative high prevalence of the mutation in the general population (0.5%) has made this association unlikely.9

References

  1. ^ a b Matsuoka S, Huang M, Elledge SJ (December 1998). "Linkage of ATM to cell cycle regulation by the Chk2 protein kinase". Science (journal) 282 (5395): 1893–7. doi:10.1126/science.282.5395.1893. PMID 9836640. 
  2. ^ Blasina A, de Weyer IV, Laus MC, Luyten WH, Parker AE, McGowan CH (January 1999). "A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase". Curr. Biol. 9 (1): 1–10. doi:10.1016/S0960-9822(99)80041-4. PMID 9889122. 
  3. ^ Chaturvedi P, Eng WK, Zhu Y, Mattern MR, Mishra R, Hurle MR, Zhang X, Annan RS, Lu Q, Faucette LF, Scott GF, Li X, Carr SA, Johnson RK, Winkler JD, Zhou BB (July 1999). "Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway". Oncogene 18 (28): 4047–54. doi:10.1038/sj.onc.1202925. PMID 10435585. 
  4. ^ Chehab NH, Malikzay A, Appel M, Halazonetis TD (February 2000). "Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53". Genes Dev. 14 (3): 278–88. doi:10.1101/gad.14.3.278. PMID 10673500. 
  5. ^ Lee JS, Collins KM, Brown AL, Lee CH, Chung JH (March 2000). "hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response". Nature 404 (6774): 201–4. doi:10.1038/35004614. PMID 10724175. 
  6. ^ "Entrez Gene: CHEK2 CHK2 checkpoint homolog (S. pombe)".
  7. ^ Meijers-Heijboer H, van den Ouweland A, Klijn J, et al (May 2002). "Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations". Nat. Genet. 31 (1): 55–9. doi:10.1038/ng879. PMID 11967536. 
  8. ^ Bell DW, Varley JM, Szydlo TE, Kang DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF, Birch JM, Li FP, Garber JE, Haber DA (December 1999). "Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome". Science (journal) 286 (5449): 2528–31. doi:10.1126/science.286.5449.2528. PMID 10617473. 
  9. ^ Evans DG, Birch JM, Narod SA (January 2008). "Is CHEK2 a cause of the Li-Fraumeni syndrome?". J. Med. Genet. 45 (1): 63–4. doi:10.1136/jmg.2007.054700. PMID 18178638. 

Further reading

  • Caspari T (2000). "How to activate p53.". Curr. Biol. 10 (8): R315–7. PMID 10801407. 
  • McGowan CH (2002). "Checking in on Cds1 (Chk2): A checkpoint kinase and tumor suppressor.". Bioessays 24 (6): 502–11. doi:10.1002/bies.10101. PMID 12111733. 
  • Honrado E, Osorio A, Palacios J, Benitez J (2006). "Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations.". Oncogene 25 (43): 5837–45. doi:10.1038/sj.onc.1209875. PMID 16998498. 
  • Nevanlinna H, Bartek J (2006). "The CHEK2 gene and inherited breast cancer susceptibility.". Oncogene 25 (43): 5912–9. doi:10.1038/sj.onc.1209877. PMID 16998506. 
  • Peng CY, Graves PR, Thoma RS, et al. (1997). "Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216.". Science 277 (5331): 1501–5. PMID 9278512. 
  • Lykidis A, Jackson PD, Rock CO, Jackowski S (1998). "The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content.". J. Biol. Chem. 272 (52): 33402–9. PMID 9407135. 
  • Lindsay HD, Griffiths DJ, Edwards RJ, et al. (1998). "S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe.". Genes Dev. 12 (3): 382–95. PMID 9450932. 
  • Matsuoka S, Huang M, Elledge SJ (1998). "Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.". Science 282 (5395): 1893–7. PMID 9836640. 
  • Martinho RG, Lindsay HD, Flaggs G, et al. (1999). "Analysis of Rad3 and Chk1 protein kinases defines different checkpoint responses.". EMBO J. 17 (24): 7239–49. doi:10.1093/emboj/17.24.7239. PMID 9857181. 
  • Blasina A, de Weyer IV, Laus MC, et al. (1999). "A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase.". Curr. Biol. 9 (1): 1–10. PMID 9889122. 
  • Brown AL, Lee CH, Schwarz JK, et al. (1999). "A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage.". Proc. Natl. Acad. Sci. U.S.A. 96 (7): 3745–50. PMID 10097108. 
  • Chaturvedi P, Eng WK, Zhu Y, et al. (1999). "Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.". Oncogene 18 (28): 4047–54. doi:10.1038/sj.onc.1202925. PMID 10435585. 
  • Ouyang B, Li W, Pan H, et al. (1999). "The physical association and phosphorylation of Cdc25C protein phosphatase by Prk.". Oncogene 18 (44): 6029–36. doi:10.1038/sj.onc.1202983. PMID 10557092. 
  • Dunham I, Shimizu N, Roe BA, et al. (1999). "The DNA sequence of human chromosome 22.". Nature 402 (6761): 489–95. doi:10.1038/990031. PMID 10591208. 
  • Bell DW, Varley JM, Szydlo TE, et al. (2000). "Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.". Science 286 (5449): 2528–31. PMID 10617473. 
  • Chehab NH, Malikzay A, Appel M, Halazonetis TD (2000). "Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.". Genes Dev. 14 (3): 278–88. PMID 10673500. 
  • Hirao A, Kong YY, Matsuoka S, et al. (2000). "DNA damage-induced activation of p53 by the checkpoint kinase Chk2.". Science 287 (5459): 1824–7. PMID 10710310. 
  • Lee JS, Collins KM, Brown AL, et al. (2000). "hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.". Nature 404 (6774): 201–4. doi:10.1038/35004614. PMID 10724175. 
  • Zhou BB, Chaturvedi P, Spring K, et al. (2000). "Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity.". J. Biol. Chem. 275 (14): 10342–8. PMID 10744722. 

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

v • d • e
Neoplasm: Tumor suppressor genes/proteins
Cell membrane
Cytosol/cytoskeleton
Mitochondria
Nucleus
see also oncogenes
v • d • e
Kinases: Serine/threonine-specific protein kinases (primarily EC 2.7.11)
2.7.11
2.7.12
MAP2K (1, 2, 3, 4, 5, 6, 7)
2.7.1.37, or unknown

Wikipedia content modification information:

  • This page was last modified on 17 November 2008, at 09:35.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "CHEK2".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.